Showing posts with label male infertility. Show all posts
Showing posts with label male infertility. Show all posts

Monday, November 12, 2018

World's most comprehensive digital roadmap to unlock male infertility

male infertility solutions,male infertility treatment,male infertility new studies
image credit: bustle.com
Millions of couples who have trouble conceiving may get relief from new research led by scientists at The University of Texas at San Antonio. The researchers have developed a high-resolution genetic map showing how men produce sperm cells. Their effort could help address genetically based challenges with male fertility, a major cause of conception problems.

The researchers' findings reveal detailed information about which genes are turned on or off in stem cells that ultimately grow into sperm cells. This data could give doctors crucial insight into the development of sperm in a patient, a perspective that was lacking up until now.

UTSA researcher Brian Hermann says the new knowledge could be a game changer for uncovering what can go wrong in men who suffer from infertility.

"We took a new, cutting-edge approach down to the level of individual cells to understand all the changes in which genes are used to make sperm in the testicles. That previously had not been possible and impedes progress toward a cure for male infertility," said Hermann, a biology professor and director of the UTSA Genomics Core.

Thursday, November 1, 2018

What is the link between varicocele and infertility?

varicocele and male infertility
Varicoceles are common, affecting 10 to 15 percent of men. Doctors continue to debate the role of varicoceles in infertility.Some research suggests that treating a varicocele may improve fertility outcomes. However, a systematic review states that the available evidence is weak and that doctors must conduct more research.

In this article, learn more about whether a varicocele affects fertility, as well as when to see a doctor.

A varicocele occurs when a bulge results from enlarged veins inside the scrotum. The swelling typically resembles an enlargement above the testicle, without discoloration.The pampiniform plexus is a group of veins inside the scrotum. These veins help cool the blood before it travels to the testicular artery, which supplies the testicles with blood.If the testicles are too hot, they cannot make healthy sperm. Sperm health affects fertility, so it is essential that the veins can cool down the blood.

Most people with a varicocele do not have symptoms, but some may experience fertility issues.When someone has a varicocele, they may also experience swelling and tenderness of the scrotum.

Thursday, September 13, 2018

Male Obesity is linked to Brain Inflammation

male obesity and brain inflamation,male infertility and male obesity
image credit: deccanchronicle.com
Whether we like it or not, everyone accumulates fat.

For women, it usually accumulates around the hips, resulting in a pear-shaped look. In men, fat tends to build up around the abdomen, creating an apple shape.

As it turns out, it's healthier to be a pear than an apple.

A research team at the University of California, Riverside, has found that only male mice experienced neuroinflammation, or activation of the immune system's response in the brain, after being fed a high-fat diet. While females were unaffected, males showed low testosterone and reduced sperm count, in addition to neuroinflammation.

Study results appear in the journal Frontiers in Immunology.

Clinical studies have led researchers to believe females are protected against weight gain when they are young because of ovarian estrogen. The understanding has been that women gain weight after menopause because of a precipitous drop in estrogen, resulting in a decline in health parameters, including obesity.

Friday, May 18, 2018

Can Depression Cause Male Infertility?

depression and male infertility,can depression cause male infertility
healthline.com
 Researchers at the National Institutes of Health combined data from two previous studies that compared the effectiveness of ovulation-inducing drugs in women with polycystic ovary syndrome and couples with unexplained fertility. Most of the 1,650 women and 1,608 men involved in the dataset formed couples.

Based on the results of a questionnaire, about 6% of women and 2% of men were rated as having major depression, and this was found to have a major impact on fertility. Men with major depression were 60% less likely to have a live birth compared to men who did not have major depression. The study did not include couples who underwent in vitro fertilization since the procedure couple potentially offset some of the effects of depression. 

Of the 34 men with major depression, only three achieved a live birth. That’s compared to nearly 25% of couple who achieved a live birth, where the male partner did not have major depression.

Depression may affect fertility in men in a number of ways, including sexual dysfunction due to reduced libido and negative change in sperm quality. For instance, a study published in 2014 found that men who had gone through two or more stressful events the previous year had lower sperm motility and a lower percentage of normal sperm. Stress also lowered testosterone levels, which is a hormone known to be heavily involved in fertility.

Previously, studies had shown that depression negatively affects fertility in women. For instance,  41 percent of women seeking fertility treatments have symptoms of depression. The present study is the first to show that depression also affects male fertility, providing “new information to consider when making treatment decisions.”

A secondary finding of the study was that a class of antidepressants known as non-selective serotonin reuptake inhibitors (non-SSRIs) was linked to a higher risk of early pregnancy loss among females being treated for infertility. SSRIs, another class of antidepressants, were not linked to pregnancy loss.

Scientific reference: Emily A. Evans-Hoeker et al. Major depression, antidepressant use, and male and female fertility, Fertility and Sterility (2018). DOI: 10.1016/j.fertnstert.2018.01.029. 

Sunday, May 13, 2018

Is Taurine Imbalance in Sperm another Reason for Male Infertility?

male infertility and taurine in sperm,is taurine deficiency in sperm a reason behind male infertility
news-medical.net
Sperm are highly specialized cells adapted to achieve a single goal: fertilize an egg. Along the road to fertilization sperm must embark on a lengthy journey to the female oviduct, avoiding several fatal stresses that occur when they pass through different physiological environments. However, the events that allow sperm cells to achieve fertilization under these conditions are only partially understood.

In a study published in The FEBS Journal, researchers at the University of Tsukuba and Cornell University report they have uncovered a cell volume regulator in sperm cells that plays a key role in maintaining their shape and fertility.

Most of a cell’s mass consists of water, and this water can determine a cell’s volume. The membrane that surrounds each cell is leaky, so cells can take in or release excess water depending on how much water surrounds them (a phenomenon known as “osmosis”). This property is analogous to how a sponge behaves–like a sponge taking on too much water, changes in water levels can drastically change the volume, and eventually the shape, of a cell.

“Cells have sensor mechanisms that let them compensate for changes in their osmotic environment,” says corresponding author Atsushi Asano, an assistant professor of the University of Tsukuba. “Without these compensatory sensors, cells would experience excessive volume changes leading to a ruptured membrane or other morphological problems. This type of sensor is fairly common in cells, but we were surprised to find one that plays a significant role in the function of sperm cells.”

Previously, it was found that male mice lacking cysteine dioxygenase (CDO) are infertile. CDO is a protein known to make the amino acid taurine, which in turn is known to play a role in osmosis. While these facts are not new, the precise role of CDO and taurine in fertilization has been a long-standing controversy.

In the study, the researchers confirmed that male mice missing CDO are indeed more likely to be infertile compared with their healthy counterparts – over 10 times more likely, in fact. They also found taurine levels dropped dramatically in the sperm cells of these mice. This suggested a clear link between the two defects, but was a conundrum in these findings: sperm are unable to make proteins, including CDO. How, then, were the sperm obtaining the taurine that was so critical to their function? The team discovered that, rather than making their own taurine, the sperm cells absorbed taurine while passing through the male genital tract.

“The absorption process looks to be an important survival strategy for sperm during fertilization, since mature sperm cannot produce proteins on their own,” co-author Ai Ushiyama says. “The findings convinced us that taurine was essential to the fertilization process, but we still had to figure out what exactly taurine was doing in sperm cells.”

The researchers keyed in on one telling clue, an unusual “kink” in the tail of the sperm. Sperm cells in CDO-deficient mice were nearly twice as likely to have a wrongly-angled tail when placed in an environment like that of a uterus. Strikingly, the defect disappeared when the sperm were supplied with extra taurine. These observations led the authors to conclude that, by controlling osmosis, taurine helped to maintain the right shape of sperm during fertilization.

“Our findings show that the production of taurine by CDO in the male reproductive tract, and its absorption by sperm, are pivotal mechanisms for male fertility,” Asano concludes. “We believe that as sperm travel through different osmotic environments, the level of taurine inside the cell shifts to balance the change in cell volume. This prevents excess changes in shape caused by an influx or efflux of water, allowing the sperm to successfully complete fertilization under difficult environmental conditions.”


 



Wednesday, May 9, 2018

Compound stops sperm from swimming without side effects

male infertilty about human sperm
A compound called EP055 binds to sperm proteins and significantly slows the overall motility of the sperm without affecting hormones.

The finding, which appear in PLOS ONE, suggest EP055 could be a candidate for contraceptive pill for men that’s free of side effects.

“Simply put, the compound turns-off the sperm’s ability to swim, significantly limiting fertilization capabilities,” says lead investigator Michael O’Rand, retired professor of cell biology and physiology in the University of North Carolina at Chapel Hill School of Medicine, and president/CEO of Eppin Pharma, Inc. “This makes EP055 an ideal candidate for non-hormonal male contraception.”

Currently, condoms and surgical vasectomy are the only safe forms of birth control currently available for men. There are hormonal drugs in clinical trials that target the production of sperm, but these affect the natural hormones in men much like female contraceptives affect hormones in women.

In 2001, O’Rand’s UNC School of Medicine lab published a paper in Gene about the discovery of the Eppin protein, which coats the entire sperm cell. They found this protein is crucial for the protection of the sperm. In 2009, O’Rand’s lab received an NIH grant to study compounds to inhibit the protein, and his team developed lead compounds that bound to Eppin.

When O’Rand retired in 2014 after 35 years, he formed Eppin Pharma Inc. with support from the UNC School of Medicine, Carolina Kickstart, and the North Carolina Biotechnology Center. The sole purpose of the company was to turn the compounds into a male contraceptive. He leased space—his old lab—and continued working on developing the lead compounds. Four years later, the company is on the cusp of developing an effective pill version of the lead compound, EP055.

During this most recent study, his team showed that thirty hours following a high-dose intravenous infusion of EP055 in male rhesus macaques at the Oregon National Primate Research Center at Oregon Health & Science University, researchers found no indication of normal sperm motility. Further, they observed no physical side effects.

“At 18 days post-infusion, all macaques showed signs of complete recovery, suggesting that the EP055 compound is indeed reversible,” says study co-investigator Mary Zelinski, research associate professor at the ONPRC at OHSU and associate professor of obstetrics and gynecology in the OHSU School of Medicine.

O’Rand and Zelinski indicate that more work is needed before EP055 becomes available for human use. Their teams have begun to develop a pill form of the compound and will eventually conduct a mating trial of EP055’s effectiveness against pregnancy.

The National Institutes of Health, Eppin Pharma Inc., and the North Carolina Biotechnology Center funded the study in part.


Monday, May 7, 2018

Researcher discovers mechanisms and epigenetic markers with implications for diseases ranging from cancers to infertility

hhmi.org
A UMD researcher has uncovered new mechanisms that dictate the development of germline stem cells or germ cells, the only cell type capable of passing genetic information on to the next generation. Stem cell research is on the foreground of new knowledge for fighting disease, and mechanisms in this study were found to be associated with genes responsible for cancers and viral infections among other major health issues. 

Markers used to identify male germ cells were also discovered, exploring how environmental factors or epigenetics affect these cells and providing significant insight into treatments for male infertility. These findings not only unlock future animal and human health research in these areas, but also set the stage for chickens as a more prominent model organism for stem cell research.

Stem cell research has applications for treating cancer, heart disease, neurological disorders like Alzheimer's disease, diabetes, and even injuries. These cells can replicate and replace damaged tissue, so understanding their development is important to the future of this work. Epigenetic factors, or environmental factors that affect the way genes are expressed, can also play a large role in cell and tissue development, and no studies have previously looked at the mechanisms at play in germline stem cell development and how epigenetics play a role.

Tuesday, October 24, 2017

New research on sperm stem cells has implications for male infertility and cancer

sperm stem cells and male infertility,cancer and sperm stem cells
via lifenews.com
"New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah and collaborators at University of Utah Health (U of U Health) sheds light on the complex process that occurs in the development of human sperm stem cells. This is the first study to characterize the changes human sperm stem cells undergo as they mature. The results have implications for understanding male infertility as well as cancer development and were published in the journal Cell Stem Cell.

Previous studies of sperm stem cells have been limited to model systems, including mice. But this first study of developing human sperm stem cells revealed this process was much more complex in humans than had been previously understood. Using genome analysis tools, scientists outlined the multistage process that sperm stem cells undergo during their normal development.

"This information yields new insights into how sperm stem cells function and develop under normal circumstances," says the study's lead author Bradley Cairns, PhD, senior director of basic science at HCI and professor and chair of oncological sciences at the U of U. "We have built a very important framework we can now use to help us understand what happens when things go wrong, resulting in issues like infertility and cancer in men..."

Learn more:

Monday, June 26, 2017

Male infertility: Urogenital infection as a possible cause

male infertility and urogenital infection,can urogenital infection cause infertility to men
image: pregnancywellnesstips.com
"In couples who have not been able to have children, male infertility is the cause in at least half of cases. In 6-10% the cause is a urogenital infection. The risk of irreversible infertility associated with urogenital infections in men should not be underestimated, say Hans-Christian Schuppe and coauthors in a review article in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2017; 114: 321-7). 

For this reason, appropriate diagnostic evaluation of infections and inflammation in men should be a component in the basic examination in couples who cannot conceive. In their article, the authors from Justus Liebig University Giessen summarize what is currently known about the possible effects of urogenital infections on male fertility and make recommendations on diagnostic and therapeutic approaches.

The main cause of inflammatory disease in the male genital tract are sexually transmitted pathogens or uropathogens (such as Chlamydia trachomatis or Escherichia coli). Furthermore, the spread of viral infections through the bloodstream needs to be considered. The diagnostic evaluation of urogenital infections in most patients with infertility is hampered by an asymptomatic primary chronic disease course. Non-invasive diagnostic markers are currently not available. Especially collecting data on asymptomatic inflammatory reactions in the epididymis and testes is difficult; the latter can be diagnosed with any degree of certainty only by using testicular biopsy. Asymptomatic inflammatory reactions are found in 25% of men who undergo testicular biopsy for infertility.

The current evidence from studies does not allow any definite conclusions about the effects of chronic prostatitis on fertility. However, it was found that after acute inflammation/infection of the epididymis, in 10% of cases no sperm was found in the ejaculate in the long term, and in 30% the number of spermatozoa were reduced; in 60% of men affected by an inflammation/infection of the epididymis, the testes were affected too. In such cases, testicular atrophy with permanent loss of spermatogenesis is a much feared complication..."

Learn more: 


Tuesday, May 30, 2017

New 'sperm radar' test may uncover secrets about male infertility

male infertility and new tests about sperm,new technique to examine human sperm
"Scientists at the University of Sheffield have developed a new technique to examine human sperm without killing them -- helping to improve the diagnosis of fertility problems.

The Magnetic Resonance Spectroscopy technique, uses powerful magnets and works like radar by firing pulses of energy at the sperm sample inside a purpose built scanner and then listening to the echoed signal by the molecules in response. This could help to distinguish between populations of good or poor sperm.

Unlike other more destructive examination methods, the low energy pulses do not damage sperm, meaning they could potentially go on to be used in IVF treatment. This is similar to a technique that doctors use to capture images of cells and tissues inside the body.

The novel approach was pioneered by physicists from the University of Sheffield's Academic Unit of Radiology working together with fertility experts from the University's Academic Unit of Reproductive and Developmental Medicine in the interdisciplinary spermNMR project.

Professor Martyn Paley, from the University's Department of Infection, Immunity and Cardiovascular Disease, said: "The technique of Magnetic Resonance Spectroscopy has been previously used to examine the molecular composition of many cells and tissues in other diseases such as cancer, but it has never previously been used to examine live sperm. As such, these results are a world first..."

Learn more:


Monday, April 3, 2017

Transport of molecular motors into cilia

sperm cell power molecular motor new research
credit: Esben Lorentzen
"Molecular motors produce the force that powers the beat of sperm cell tails to generate movement toward the egg cell for fertilization. New research now shows how the molecular motors that power the movement of sperm cells are recognized and specifically transported into the tail region of the cell. This knowledge can pave the way for a better understanding of disease causing mutations causing sterility.

Molecular motors use the molecule ATP as energy source to organize the inner life of cells. Dyneins are the largest and most complex molecular motors and are responsible for intracellular transport and for generation of the force required for motility of cilium organelles. Cilia are thin structures found on the surface of our cells where they function as sensors receiving signals from the environment and as motors causing the cell or the environment to move.

Motile cilia are found as a single copy on sperm cells and in multiple copies on cells in our lungs where they generate a fluid flow necessary for the removal of dust particles and pathogens from the airways. The large dynein motors (known as 'outer dynein arms´, ODA) -- that are necessary for the motility of cilia -- are actively transported into cilia via the intraflagellar transport (IFT) system and the transport adaptor ODA16. Mutations in dynein motors or IFT factors can result in infertility and respiratory deficiency..."

Learn more: 


Friday, March 31, 2017

Using a smartphone to screen for male infertility

smartphones to screen male infertility
via umts-stick.org
"More than 45 million couples worldwide grapple with infertility, but current standard methods for diagnosing male infertility can be expensive, labor-intensive and require testing in a clinical setting. Cultural and social stigma, and lack of access in resource-limited countries, may prevent men from seeking an evaluation. 

Investigators at Brigham and Women's Hospital and Massachusetts General Hospital set out to develop a home-based diagnostic test that could be used to measure semen quality using a smartphone-based device. New findings by the team indicating that the smartphone-based semen analyzer can identify abnormal semen samples based on sperm concentration and motility criteria with approximately 98 percent accuracy are published online on March 22 in Science Translational Medicine.

"We wanted to come up with a solution to make male infertility testing as simple and affordable as home pregnancy tests," said Hadi Shafiee, PhD, a principal investigator in the Division of Engineering in Medicine and Renal Division of Medicine at BWH. "Men have to provide semen samples in these rooms at a hospital, a situation in which they often experience stress, embarrassment, pessimism and disappointment. Current clinical tests are lab-based, time-consuming and subjective. This test is low-cost, quantitative, highly accurate and can analyze a video of an undiluted, unwashed semen sample in less than five seconds."

The analyzer consists of an optical attachment that can connect to a smartphone and a disposable device onto which a semen sample can be loaded. The new test utilizes the advancements in consumer electronics and microfabrication..."

Learn more:


Friday, March 10, 2017

Male infertility research reveals how a new life begins

male infertility and genetic mutation,human sperm and male infertility
"Research into a genetic mutation causing some men to be infertile shows that an important protein in the sperm that is a key component of the egg fertilization process, known as phospholipase C zeta (PLC-zeta), is ineffective in these individuals.

The investigators found that they could restart the fertilization process in the lab by injecting eggs with a higher amount of the PLC-zeta protein from the infertile men than found naturally in their sperm, which suggests that this type of infertility could become reversible with medical assistance.

"Recent clinical studies have highlighted the crucial importance of PLC-zeta in human fertilization, reporting that sperm from infertile patients, who exhibited failed fertilization even after the most powerful in vitro fertilization techniques, contained either reduced amounts or mutated forms of this protein," said Dr Michail Nomikos (Qatar University, Doha, Qatar) lead author of the Biochemical Journal paper.

"Our ultimate goal is to use the tools that we are currently developing not only to treat, but also diagnose, the cases of male infertility associated with absent or dysfunctional PLC-zeta protein in human sperm."

It has been known for some time that an essential part of the human fertilization process is a repetitive, dramatic increase in calcium levels in the egg known as 'calcium oscillations' triggered by a message from the sperm that happens just before an embryo begins to form. This calcium increase is vital for all the early events of fertilization and early embryo development..."

Learn More:


Monday, February 20, 2017

Infertility in cancer patients: drug to prevent infections may also help regenerate sperm from stem cells

male infertility,cancer,sperm,stem cells
via human-fertility.com
"A new study led by Brian Hermann, assistant professor of biology at The University of Texas at San Antonio (UTSA), shows promising evidence that a medication previously used to prevent infections in cancer patients can also keep them from becoming infertile. Losing fertility is a frequent problem among cancer patients, as treatments for the disease often halt sperm production.

Hermann and his research team have been pursuing a number of cutting-edge research initiatives to restore fertility in men who have lost their ability to have children as a result of cancer treatments they received as children. While working on methods to restart sperm production, the researchers discovered a link between a drug for recovering cancer patients and the absence of normal damage to reproductive ability.

The drug is called G-CSF or granulocyte colony-stimulating factor. It stimulates the bone marrow to produce neutrophils, which are white blood cells that are needed to fight infections. They're commonly lost after chemotherapy and radiation treatments.

"We were using G-CSF to prevent infections in our research experiments," Hermann said. "It turned out that the drug also had the unexpected impact of guarding against male infertility..."

Learn more:

Wednesday, October 12, 2016

First results from the world’s oldest group of ICSI men show they have lower semen quantity and quality

low sperm quality and quantity,icsi injection for male infertility,male infertility,infertility
"First results from the world's oldest group of young men conceived by means of intracytoplasmic sperm injection (ICSI) fertility treatment because of their fathers' infertility have shown that they have lower sperm quantity and quality than men who were spontaneously conceived.

The study, which is published today (Thursday) in Human Reproduction, has found that these men, who were aged between 18 to 22, had almost half the sperm concentration and a two-fold lower total sperm count [1] and total count of motile sperm (sperm that could swim well) than did naturally conceived men of a similar age.

In addition, compared to men born after spontaneous conception, ICSI men were nearly three times more likely to have sperm concentrations below 15 million per millilitre of semen, which is the World Health Organisation's definition of "normal," and four times more likely to have total sperm counts below 39 million..."

Learn more:

Wednesday, June 8, 2016

Opioids regulate spermatozoon formation, research shows

opioids and spermatozoon formation,spermatogenesis and opioids,male infertility and sperm molecular mechanisms

Source: University of the Basque Country | Summary: Infertility has become a major medical and social problem worldwide and many of the cases are due to male infertility. Yet the molecular mechanisms involved in spermatogenesis are only now beginning to emerge. A piece of research has, for the first time, described the presence of opioids in the cells involved in the formation of spermatozoa.

"Infertility has become a major medical and social problem worldwide and many of the cases are due to male infertility. Yet the molecular mechanisms involved in spermatogenesis are only now beginning to emerge. A piece of research led by the UPV/EHU doctor Nerea Subirán has for the first time described the presence of opioids in the cells involved in the formation of spermatozoa. The work has been published in Plos One.

In recent years, over 3% of births per year in developed countries have corresponded to children conceived through assisted reproduction techniques, which poses a considerable economic burden apart from physical and psychological problems. According to the World Health Organisation, the cases of infertility have increased exponentially in developed countries during the last 10 years. 

Specifically, male infertility represents about half of the cases of infertility. Failures during the production of spermatozoa, in other words, during spermatogenesis, produce non-functional or low-quality spermatozoa and therefore infertility. Yet the molecular mechanisms involved in the regulation of this process remain unknown despite their importance in reproductive health..."

Learn more:


Monday, May 23, 2016

World Report on Fertility Treatments: High Use of Intracytoplasmic Sperm Injection

fertility treatments and intracytoplasmic sperm injection,male infertility and high use of intracytoplasmic sperm injection
Source: European Society of Human Reproduction and Embryology | Summary: Experts have attacked the rising use of intracytoplasmic sperm injection (ICSI) for the treatment of infertility, following publication of the latest world report on assisted reproductive technologies.

"The editor-in-chief of one of the world's leading reproductive medicine journals has attacked the rising use of intracytoplasmic sperm injection (ICSI) for the treatment of infertility, following publication of the latest world report on assisted reproductive technologies (ART) [1] today (Saturday).

The report in Human Reproduction shows that while ICSI use has levelled off in some regions, its use is approaching 100% of assisted reproduction cycles in the Middle East and a few countries in other regions, despite the fact that ICSI was developed for the treatment of male infertility, which is a factor in around 40% of couples seeking fertility treatment [2]. The world report covers the years 2008, 2009 and 2010 -- the years for which the most recent data are available.

In an editorial entitled "Santa Claus in the fertility clinic" [3], to accompany the world report by the International Committee for Monitoring Assisted Reproductive Technologies (ICMART), Professor Hans Evers highlights the fact that in 2010 there were 220,000 in vitro fertilisation (IVF) treatments, but there were more than 455,000 ICSI treatments in the world. There was 1.4 times as much ICSI than IVF in Asia, twice as much in sub-Saharan Africa, just over twice as much in Europe, 2.7 times as much in North America, more than six times as much in Latin America and more than 60 times as much in the Middle East..."

Read more here:


Tuesday, March 29, 2016

Fertile discovery: Treating male infertility with synthetic protein

male infertility and synthetic protein,treating male infertility with synthetic protein
Source: Queen's University | Summary: A promising method of treating male infertility using a synthetic version of the sperm-originated protein known as PAWP has been developed by researchers. The research promises to diagnose and treat cases of male factor infertility where a patient's sperm is unable to initiate or induce activation of the egg to form an early embryo.

"Queen's University researcher Richard Oko and his co-investigators have come up with a promising method of treating male infertility using a synthetic version of the sperm-originated protein known as PAWP.

They found this protein is sufficient and required to initiate the fertilization process.

Dr. Oko's research promises to diagnose and treat cases of male factor infertility where a patient's sperm is unable to initiate or induce activation of the egg to form an early embryo.

"PAWP is able to induce embryo development in human eggs in a fashion similar to the natural triggering of embryo development by the sperm cell during fertilization," explains Dr. Oko (Biomedical and Molecular Sciences). "Based on our findings, we envision that physicians will be able to improve their diagnosis and treatment of infertility, a problem that affects 10 to 15 per cent of couples worldwide."

The results of this study highlight the potential clinical applications of sperm PAWP as a predictor of infertility treatment. Since most human infertility treatments are now done by injecting a single sperm directly into an egg, supplementation of human sperm with PAWP protein may potentially be used to improve the success rate of infertility treatments in the future..."

Read more here:


Tuesday, March 15, 2016

Almost 1/3 of infertile men at increased risk of metabolic diseases as they age

male infertility and metabolic diseases,male infertility
via 

Source:  European Association of Urology | Summary: Men with fertility problems are at increased risk of metabolic diseases as they age, according to new research.

"Men with fertility problems are at increased risk of metabolic diseases as they age, according to work being presented at the European Association of Urology conference in Munich*.

Around fifteen percent of all couples experience infertility, and in around half of these cases this is due to male infertility. Men with poor semen quality have been shown to have a decreased life expectancy, but the cause are unknown and no biochemical markers or prevention strategies have been developed. 

Now a group of Swedish researchers have measured the levels of sex hormones and other biochemical parameters in infertile men, and have shown that many of them are at risk of hypogonadism (low levels of sex hormones) as well as signs of metabolic disease and osteoporosis.

The group took 192 men with a low sperm count, who were attending the Reproductive Medicine Centre at Skåne University Hospital, Malmö, and compared them with 199 age-matched controls. They compared sex hormone levels between the groups, as well as other markers such as bone mineral density (which indicates risk of osteoporosis) and HbA1c (a biomarker for diabetes)..."


Read more here:
https://www.sciencedaily.com/releases/2016/03/160314085049.htm

Wednesday, February 17, 2016

Male cancer survivors less likely to reproduce

male cancer survivors and infertility,infertility and male cancer
via examiner.com
Source: University of Bergen | Summary: Young male cancer survivors are three times as likely to turn to assisted fertilization to have children as males without a cancer diagnosis. This knowledge makes it possible to develop concrete treatment protocols, which affect fertility to a lesser degree, say authors of a new report.

"Young male cancer survivors are three times as likely to turn to assisted fertilization to have children as males without a cancer diagnosis. This knowledge makes it possible to develop concrete treatment protocols, which affect fertility to a lesser degree. Measures like preserving sperm before starting treatment can be optimised. Close to 80 per cent of those diagnosed during childhood or adolescence will survive their cancer.

According to a Norwegian study of male cancer patients diagnosed under the age of 25, many male cancer patients have problems reproducing. The researchers hope this new knowledge may contribute to changing future treatment of male cancer patients.

A study of all Norwegian men born between 1965 and 1985 shows that male cancer survivors are less likely to have children than those without a cancer diagnosis.

"These finds are important for male cancer survivors, seeing as we can identify groups at risk of having reproduction problems," says Maria Winther Gunnes, PhD candidate at the Department of Global Public Health and Primary Care at the University of Bergen (UiB) and lead author of a recently published article in the British Journal of Cancer..."


Read the rest of the article: https://www.sciencedaily.com/releases/2016/02/160216090854.htm